Researchers found that an AI tool called Unfold AI, developed by researchers at UCLA and Avenda Health, accurately estimates prostate tumor volume and helps identify patients with a higher chance of successful treatment.
The researchers have demonstrated the tool's potential by identifying a promising candidate to prevent heart failure, a leading cause of death in the United States and around the world.
The research, led by researcher dr. Guido Giunti and neurologists dr. Mervi Ryytty and assistant professor Johanna Krüger from the University of Oulu and Oulu University Hospital in Finland, evaluated the feasibility, usability, and impact of More Stamina over a 60-day period.
Multidomain interventions, including games and exercises delivered through smartphone-based apps, have also proven effective in slowing cognitive decline in this population.
Over the course of eight weeks, the participants’ average blood pressure readings decreased from 139/87 mmHG to a more manageable 126/83 mmHg.
To increase accessibility to cognitive assessments, a team of researchers at the University of Missouri created a portable system to efficiently measure multiple aspects of motor function.
The study, publishing March 11 in JAMA Network Open, showed high overall satisfaction with communications written both by AI and humans, despite their preference for AI.